Fasiplon

Nowadays, Fasiplon is a topic of increasing interest in modern society. With the advancement of technology and globalization, Fasiplon has become increasingly relevant in our lives. From its impact on the economy to its cultural implications, Fasiplon has been the subject of debate and analysis in different areas. In this article, we will explore the many facets of Fasiplon and its influence on our daily lives. From its history to its future projection, we will dive into an in-depth analysis of Fasiplon and its role today.

Fasiplon
Clinical data
ATC code
  • none
Identifiers
  • 6-Ethyl-7-methoxy-5-methyl-2-(5-methyl-oxadiazol-3-yl)-imidazopyrimidine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H15N5O2
Molar mass273.296 g·mol−1
3D model (JSmol)
  • CC1=NC(C2=CN3C(N=C(OC)C(CC)=C3C)=N2)=NO1
  • InChI=1S/C13H15N5O2/c1-5-9-7(2)18-6-10(11-14-8(3)20-17-11)15-13(18)16-12(9)19-4/h6H,5H2,1-4H3 ☒N
  • Key:MEBYKPLMXIRYRQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Fasiplon (RU 33203) is a nonbenzodiazepine anxiolytic drug from the imidazopyrimidine family of drugs.

Fasiplon binds strongly to benzodiazepine sites on the GABAA receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action. It was developed by a team at Roussel Uclaf in the 1990s

References

  1. ^ Tully WR, Gardner CR, Gillespie RJ, Westwood R (July 1991). "2-(oxadiazolyl)- and 2-(thiazolyl)imidazopyrimidines as agonists and inverse agonists at benzodiazepine receptors". Journal of Medicinal Chemistry. 34 (7): 2060–7. doi:10.1021/jm00111a021. PMID 1648620.
  2. ^ US Patent 5869481 Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
Wikious
Boobota
Sagapedia